Telemetry Investments, L.L.C. Rigel Pharmaceuticals Inc Transaction History

Telemetry Investments, L.L.C.

$63.3 Million
Q4 2022

A detailed history of Telemetry Investments, L.L.C. transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 322,500 shares of RIGL stock, worth $4.42 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

322,500

Previous 200,000 61.25%

Holding current value

$4.42 Million

Previous $236,000 105.08%

% of portfolio

0.76%

Previous 0.3%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $82,075 - $1.46 Million	122,500 Added 61.25%	322,500 $484,000
Q3 2022 Nov 17, 2022	SELL	$1.1 - $12.2 $33,000 - $366,000	-30,000 Reduced 13.04%	200,000 $236,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $63,650 - $303,050	95,000 Added 70.37%	230,000 $260,000
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $122,100 - $189,750	-55,000 Reduced 28.95%	135,000 $404,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $159,300 - $240,975	67,500 Added 55.1%	190,000 $504,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $148,750 - $191,250	42,500 Added 53.13%	122,500 $445,000
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $30,900 - $45,400	-10,000 Reduced 11.11%	80,000 $347,000
Q1 2021 May 17, 2021	SELL	$3.35 - $4.93 $53,630 - $78,924	-16,009 Reduced 15.1%	90,000 $308,000
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $514,628 - $819,026	-218,991 Reduced 67.38%	106,009 $371,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $177,110 - $410,935	99,500 Added 44.12%	325,000 $780,000
Q4 2019 Feb 14, 2020	SELL	$1.6 - $2.43 $3,200 - $4,860	-2,000 Reduced 0.88%	225,500 $483,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $10,595 - $17,030	-6,500 Reduced 2.78%	227,500 $425,000
Q2 2019 Aug 14, 2019	SELL	$2.02 - $2.61 $133,320 - $172,260	-66,000 Reduced 22.0%	234,000 $611,000
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $80,000 - $106,000	40,000 Added 15.38%	300,000 $771,000
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $289,120 - $467,040	139,000 Added 114.88%	260,000 $598,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $153,400 - $211,810	-59,000 Reduced 32.78%	121,000 $388,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $155,650 - $226,050	55,000 Added 44.0%	180,000 $509,000
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $406,746 - $521,646	-114,900 Reduced 47.89%	125,000 $442,000
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $128,877 - $171,570	39,900 Added 19.95%	239,900 $931,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $436,000 - $513,999	200,000	200,000 $508,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

355K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.37B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Account

Telemetry Investments, L.L.C. Rigel Pharmaceuticals Inc Transaction History